US Broker Ratings

ADMA Biologics Inc (ADMA) Stock Analysis: Exploring a Potential 48% Upside in the Biotech Sector

ADMA Biologics Inc (NASDAQ: ADMA) is drawing significant attention within the healthcare sector, especially among investors keen on biotechnology stocks. The company, with a market cap of $4.13 billion, is..

BridgeBio Pharma, Inc. (BBIO) Stock Analysis: Unveiling a 16.64% Potential Upside in Biotechnology

BridgeBio Pharma, Inc. (BBIO) is making waves in the biotechnology sector with its innovative approach to addressing genetic diseases and cancers. As a commercial-stage biopharmaceutical company, BridgeBio focuses on discovering,..

Charles River Laboratories (CRL) Stock Analysis: Navigating the Healthcare Sector with Strategic Collaborations

Charles River Laboratories International, Inc. (NYSE: CRL), a prominent player in the healthcare sector, is attracting significant attention from investors with its strategic alliances and specialized services. Operating within the..

Teleflex Incorporated (TFX) Stock Analysis: Navigating a Potential 27% Upside in a Challenging Market

Teleflex Incorporated (NYSE: TFX), a stalwart in the healthcare sector, stands at a pivotal juncture. The company, known for its innovative medical instruments and supplies, has captured investor attention with..

Tempus AI, Inc. (TEM) Stock Analysis: Healthcare Disruptor with 25% Upside Potential

Tempus AI, Inc. (NASDAQ: TEM), a burgeoning player in the healthcare technology sector, has been making waves with its innovative solutions in health information services. Headquartered in Chicago, Illinois, this..

Halozyme Therapeutics, Inc. (HALO) Stock Analysis: A Biotech Leader with an 8.31% Potential Upside

Halozyme Therapeutics, Inc. (NASDAQ: HALO) stands out in the biotechnology sector with a market capitalization of $8.37 billion, offering a robust portfolio of innovative products and strategic partnerships. The company’s..

Vaxcyte, Inc. (PCVX): Investor Outlook on a Potential 119% Upside in the Biotech Sector

Vaxcyte, Inc. (NASDAQ: PCVX) stands as a noteworthy player in the biotechnology sector, captivating investors with its promising portfolio of vaccine candidates and an impressive potential upside of 119.17%. Based..

Hologic, Inc. (HOLX) Stock Analysis: Navigating Growth in Women’s Health with a 1.92% Upside Potential

Hologic, Inc. (NASDAQ: HOLX) has established itself as a pivotal player in the healthcare sector, specifically within the medical instruments and supplies industry. With a robust market capitalization of $16.73..

Moderna, Inc. (MRNA) Stock Analysis: Navigating Challenges with Strategic Collaborations

Moderna, Inc. (NASDAQ: MRNA) has established itself as a notable player in the biotechnology industry, particularly through its pioneering work in messenger RNA (mRNA) technologies. With a market capitalization standing..

Doximity, Inc. (DOCS) Stock Analysis: Navigating a 57.78% Upside Potential in the Health Information Sector

Investors looking for opportunities in the healthcare technology space might find Doximity, Inc. (NYSE: DOCS) an intriguing proposition. With a market capitalization of $7.77 billion, Doximity has carved out a..

Bruker Corporation (BRKR) Stock Analysis: Exploring 11.74% Potential Upside and Strategic Positioning in the Medical Devices Sector

Bruker Corporation (NASDAQ: BRKR), a prominent player in the healthcare sector, particularly in the medical devices industry, has caught the attention of investors with its significant growth potential. Headquartered in..

STERIS plc (STE) Stock Analysis: Exploring Growth Potential and Analyst Insights

STERIS plc (NYSE: STE) stands as a formidable player in the healthcare sector, specializing in medical devices. This Ireland-based company, with its headquarters in Mentor, Ohio, has gained significant attention..

Madrigal Pharmaceuticals (MDGL) Stock Analysis: Exploring a Promising 22% Upside in the Biotech Sector

Madrigal Pharmaceuticals, Inc. (MDGL) is making waves in the biotechnology sector, capturing investor attention with its innovative focus on metabolic dysfunction-associated steatohepatitis (MASH). With a market capitalization of $11.39 billion,..

GSK plc (GSK) Stock Analysis: Strong Revenue Growth and High ROE Capture Investor Attention

GSK plc (NYSE: GSK), a leading figure in the healthcare sector, continues to present a compelling case for investors with its diverse portfolio of vaccines and specialty medicines. Headquartered in..

Guardant Health, Inc. (GH) Stock Analysis: Unlocking Potential in Precision Oncology with a Robust Revenue Growth

Guardant Health, Inc. (NASDAQ: GH) stands at the forefront of the precision oncology field, offering groundbreaking diagnostic and research services that hold significant promise for both patients and investors. With..

ResMed Inc. (RMD) Stock Analysis: Navigating the Sleep Health Giant’s 13.49% Potential Upside

ResMed Inc. (NYSE: RMD), a prominent player in the healthcare sector, particularly within the medical instruments and supplies industry, has garnered attention from investors due to its robust market presence..

Bio-Techne Corp (TECH) Stock Analysis: Navigating a Competitive Biotech Landscape with Strategic Growth Potential

Bio-Techne Corporation (NASDAQ: TECH) stands as a prominent player in the biotechnology industry, a sector characterized by rapid innovation and intense competition. With a market capitalization of $10.7 billion, the..

Legend Biotech Corporation (LEGN) Stock Analysis: A Biotech with a Staggering 218% Potential Upside

Legend Biotech Corporation (NASDAQ: LEGN) is capturing the attention of investors in the biotechnology sector with its impressive growth potential and innovative approach to cancer treatment. With a market capitalization..

Illumina, Inc. (ILMN) Stock Analysis: Navigating a Tightrope Between Innovation and Valuation

Illumina, Inc. (NASDAQ: ILMN) stands as a pivotal player in the healthcare sector, specifically within diagnostics and research. With a market capitalization of $21.77 billion, Illumina has carved out a..

Neurocrine Biosciences, Inc. (NBIX): Exploring a 35.65% Potential Upside in the Healthcare Sector

Neurocrine Biosciences, Inc. (NASDAQ: NBIX) stands at a fascinating juncture within the healthcare sector, specifically in the drug manufacturing industry. With a substantial market capitalization of $13.2 billion, this San..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds